Giuseppe Curigliano/bigagainstbreastcancer.org
Mar 26, 2025, 18:03
Molecular tumour board in gastrointestinal cancers
ESMO Open shared a post on X about a recent paper by L. Boscolo Bielo et al. published in ESMO Open:
“Retrospective analysis of MTB impact on the care of patients with GI tumors at The European Institute of Oncology just published in ESMO Open.
Among 192 patients discussed at the MTB, 31 (17.7%) were recommended molecularly guided treatment options, experiencing longer rwPFS.”
Molecular tumour board in gastrointestinal cancers
Authors: L. Boscolo Bielo, G. Curigliano, et al.
More posts featuring ESMO Open.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 18, 2025, 20:22
Apr 18, 2025, 20:12
Apr 18, 2025, 20:03
Apr 18, 2025, 19:54
Apr 18, 2025, 19:49
Apr 18, 2025, 19:44
Apr 18, 2025, 19:26